J&J’s COVID-19 vaccine candidate sparks hopes for faster recovery, just as daily deaths spike above 5,000 in the U.S.
February 05, 2021 at 11:57 AM EST
Hopes for a quicker recovery from the COVID-19 pandemic got a boost Friday, after the Food and Drug Administration said it would review Johnson & Johnson's COVID-19 vaccine candidate before the end of the month.
